Journal of the American Society of Nephrology, Vol 7, 661-666, Copyright © 1996 by American Society of Nephrology

REGULAR ARTICLES

Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases

K Shulman, S Rosen, K Tognazzi, EJ Manseau and LF Brown
Department of Pathology, Beth Israel Hospital, Boston, MA 02215, USA.

Vascular permeability factor (VPF), also known as vascular endothelial growth factor (VEGF), is a potent enhancer of microvascular permeability and a selective endothelial cell growth factor. In normal human kidney, VPF/VEGF mRNA and protein are strongly expressed by visceral glomerular epithelial cells, and VPF/VEGF may be an important regulator of glomerular endothelial cell function. This study examined 47 renal biopsies from patients with a variety of glomerular diseases for expression of VPF/VEGF mRNA and protein by in situ hybridization and immunohisto-chemistry. In many glomerular diseases, VPF/VEGF- expressing cells were decreased in number or absent in areas of focal or global glomerular sclerosis. Decreased numbers of VPF/VEGF- expressing cells in glomeruli were also noted in amyloidosis, diabetes, crescentic glomerulonephritis, and diffuse endocapillary proliferative glomerulonephritis associated with systemic lupus erythematosus. Normally, release of VPF/ VEGF must be under strict control because it is some 50,000 times more potent than histamine as an inducer of microvascular permeability. Damage to visceral epithelial cells in a variety of glomerular diseases has the potential for releasing relatively large amounts of VPF/VEGF locally, leading to increased glomerular permeability. In addition, because VPF/ VEGF is also an endothelial growth factor, the loss of normal, controlled secretion of VPF/VEGF after damage to visceral epithelial cells could lead to important alterations in glomerular endothelial cell function.

This article has been cited by other articles:

				V. Campean, B. Karpe, C. Haas, A. Atalla, H. Peters, H. Rupprecht, S. Liebner, T. Acker, K. Plate, and K. Amann Angiopoietin 1 and 2 gene and protein expression is differentially regulated in acute anti-Thy1.1 glomerulonephritis Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1174 - F1184. [Abstract] [Full Text] [PDF]

				J. J. Wang, S. X. Zhang, R. Mott, Y. Chen, R. R. Knapp, W. Cao, and J.-x. Ma Anti-inflammatory effects of pigment epithelium-derived factor in diabetic nephropathy Am J Physiol Renal Physiol, May 1, 2008; 294(5): F1166 - F1173. [Abstract] [Full Text] [PDF]

				X.-B. Liang, L.-J. Ma, T. Naito, Y. Wang, M. Madaio, R. Zent, A. Pozzi, and A. B. Fogo Angiotensin Type 1 Receptor Blocker Restores Podocyte Potential to Promote Glomerular Endothelial Cell Growth J. Am. Soc. Nephrol., July 1, 2006; 17(7): 1886 - 1895. [Abstract] [Full Text] [PDF]

				M. E.J. Reinders, T. J. Rabelink, and D. M. Briscoe Angiogenesis and Endothelial Cell Repair in Renal Disease and Allograft Rejection J. Am. Soc. Nephrol., April 1, 2006; 17(4): 932 - 942. [Abstract] [Full Text] [PDF]

				K. Doi, E. Noiri, A. Nakao, T. Fujita, S. Kobayashi, and K. Tokunaga Functional Polymorphisms in the Vascular Endothelial Growth Factor Gene Are Associated with Development of End-Stage Renal Disease in Males J. Am. Soc. Nephrol., March 1, 2006; 17(3): 823 - 830. [Abstract] [Full Text] [PDF]

				A. M. Summers, B. M. Coupes, M. F. Brennan, S. A. Ralph, C. D. Short, and P. E. C. Brenchley VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5 Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2427 - 2432. [Abstract] [Full Text] [PDF]

				B. F. Schrijvers, A. S. De Vriese, and A. Flyvbjerg From Hyperglycemia to Diabetic Kidney Disease: The Role of Metabolic, Hemodynamic, Intracellular Factors and Growth Factors/Cytokines Endocr. Rev., December 1, 2004; 25(6): 971 - 1010. [Abstract] [Full Text] [PDF]

				P. H. Lapchak, M. Melter, S. Pal, J. A. Flaxenburg, C. Geehan, M. H. Frank, D. Mukhopadhyay, and D. M. Briscoe CD40-induced transcriptional activation of vascular endothelial growth factor involves a 68-bp region of the promoter containing a CpG island Am J Physiol Renal Physiol, September 1, 2004; 287(3): F512 - F520. [Abstract] [Full Text] [PDF]

				G. Boner, A. J. Cox, D. J. Kelly, A. Tobar, J. Bernheim, R. G. Langham, M. E. Cooper, and R. E. Gilbert Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease? Nephrol. Dial. Transplant., November 1, 2003; 18(11): 2293 - 2299. [Abstract] [Full Text] [PDF]

				M. B. Rookmaaker, A. M. Smits, H. Tolboom, K. van 't Wout, A. C. Martens, R. Goldschmeding, J. A. Joles, A. J. van Zonneveld, H.-J. Grone, T. J. Rabelink, et al. Bone-Marrow-Derived Cells Contribute to Glomerular Endothelial Repair in Experimental Glomerulonephritis Am. J. Pathol., August 1, 2003; 163(2): 553 - 562. [Abstract] [Full Text] [PDF]

				P.D.S. Telles, C.T. Hanks, M.A.A.M. Machado, and J.E. Nor Lipoteichoic Acid Up-regulates VEGF Expression in Macrophages and Pulp Cells J. Dent. Res., June 1, 2003; 82(6): 466 - 470. [Abstract] [Full Text] [PDF]

				D. Creamer, M. Allen, R. Jaggar, R. Stevens, R. Bicknell, and J. Barker Mediation of Systemic Vascular Hyperpermeability in Severe Psoriasis by Circulating Vascular Endothelial Growth Factor Arch Dermatol, June 1, 2002; 138(6): 791 - 796. [Abstract] [Full Text] [PDF]

				D.-H. Kang, J. Kanellis, C. Hugo, L. Truong, S. Anderson, D. Kerjaschki, G. F. Schreiner, and R. J. Johnson Role of the Microvascular Endothelium in Progressive Renal Disease J. Am. Soc. Nephrol., March 1, 2002; 13(3): 806 - 816. [Abstract] [Full Text] [PDF]

				E. Pillebout, M. Burtin, H. T. Yuan, P. Briand, A. S. Woolf, G. Friedlander, and F. Terzi Proliferation and Remodeling of the Peritubular Microcirculation after Nephron Reduction : Association with the Progression of Renal Lesions Am. J. Pathol., August 1, 2001; 159(2): 547 - 560. [Abstract] [Full Text]

				D.-H. KANG, A. H. JOLY, S.-W. OH, C. HUGO, D. KERJASCHKI, K. L. GORDON, M. MAZZALI, J. A. JEFFERSON, J. HUGHES, K. M. MADSEN, et al. Impaired Angiogenesis in the Remnant Kidney Model: I. Potential Role of Vascular Endothelial Growth Factor and Thrombospondin-1 J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1434 - 1447. [Abstract] [Full Text] [PDF]

				D.-H. KANG, J. HUGHES, M. MAZZALI, G. F. SCHREINER, and R. J. JOHNSON Impaired Angiogenesis in the Remnant Kidney Model: II. Vascular Endothelial Growth Factor Administration Reduces Renal Fibrosis and Stabilizes Renal Function J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1448 - 1457. [Abstract] [Full Text] [PDF]

				P. Vuorela, S. Andersson, O. Carpen, O. Ylikorkala, and E. Halmesmaki Unbound vascular endothelial growth factor and its receptors in breast, human milk, and newborn intestine Am. J. Clinical Nutrition, November 1, 2000; 72(5): 1196 - 1201. [Abstract] [Full Text] [PDF]

				K. Matsushita, R. Motani, T. Sakuta, S. Nagaoka, T. Matsuyama, K. Abeyama, I. Maruyama, H. Takada, and M. Torii Lipopolysaccharide Enhances the Production of Vascular Endothelial Growth Factor by Human Pulp Cells in Culture Infect. Immun., April 1, 1999; 67(4): 1633 - 1639. [Abstract] [Full Text] [PDF]

				C. PUPILLI, L. LASAGNI, P. ROMAGNANI, F. BELLINI, M. MANNELLI, N. MISCIGLIA, C. MAVILIA, U. VELLEI, D. VILLARI, and M. SERIO Angiotensin II Stimulates the Synthesis and Secretion of Vascular Permeability Factor/Vascular Endothelial Growth Factor in Human Mesangial Cells J. Am. Soc. Nephrol., February 1, 1999; 10(2): 245 - 255. [Abstract] [Full Text]

Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673